Lavipharm has signed an agreement for the sale of all its shares in Pharma Plus Pharma Plus Pharmacy Services SA, corresponding to 100% of the paid-up share capital, to Diorama Investments II RAIF, SCA.

According to the announcement, the consideration for a price, which includes a fixed amount of €1,50 million and a variable amount to be determined based on the company's future financial performance, The transfer of the shares and payment of the fixed amount of the consideration is expected to take place in approximately twenty (20) business days from the date of signing of the SPA.

Please note that Diorama Investments II RAIF, SCA, is an investment fund managed by Deca Investments AEDOEE.